Brokers Offer Predictions for HRTX Q2 Earnings
Heron Therapeutics, Inc. (NASDAQ:HRTX – Free Report) – Northland Capmk issued their Q2 2025 earnings per share estimates for shares of Heron Therapeutics in a report released on Tuesday, May 6th. Northland Capmk analyst C. Byrnes forecasts that the biotechnology company will earn ($0.01) per share for the quarter. The consensus estimate for Heron Therapeutics’ […]
